chr13-110172917-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.3506-147C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 731,658 control chromosomes in the GnomAD database, including 8,490 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1424 hom., cov: 33)
Exomes 𝑓: 0.14 ( 7066 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.15

Publications

3 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 13-110172917-G-T is Benign according to our data. Variant chr13-110172917-G-T is described in ClinVar as Benign. ClinVar VariationId is 1251886.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.159 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.3506-147C>A intron_variant Intron 40 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.3506-147C>A intron_variant Intron 40 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.119
AC:
18146
AN:
152100
Hom.:
1425
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0340
Gnomad AMI
AF:
0.143
Gnomad AMR
AF:
0.115
Gnomad ASJ
AF:
0.145
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.123
Gnomad FIN
AF:
0.241
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.161
Gnomad OTH
AF:
0.0969
GnomAD4 exome
AF:
0.144
AC:
83484
AN:
579440
Hom.:
7066
AF XY:
0.145
AC XY:
45135
AN XY:
310604
show subpopulations
African (AFR)
AF:
0.0333
AC:
540
AN:
16198
American (AMR)
AF:
0.111
AC:
3823
AN:
34586
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
2606
AN:
19148
East Asian (EAS)
AF:
0.000273
AC:
9
AN:
32932
South Asian (SAS)
AF:
0.135
AC:
8443
AN:
62346
European-Finnish (FIN)
AF:
0.228
AC:
10736
AN:
47134
Middle Eastern (MID)
AF:
0.0904
AC:
359
AN:
3972
European-Non Finnish (NFE)
AF:
0.159
AC:
52745
AN:
332242
Other (OTH)
AF:
0.137
AC:
4223
AN:
30882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3550
7101
10651
14202
17752
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
384
768
1152
1536
1920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.119
AC:
18141
AN:
152218
Hom.:
1424
Cov.:
33
AF XY:
0.123
AC XY:
9124
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0339
AC:
1410
AN:
41556
American (AMR)
AF:
0.115
AC:
1758
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.145
AC:
502
AN:
3472
East Asian (EAS)
AF:
0.00173
AC:
9
AN:
5194
South Asian (SAS)
AF:
0.123
AC:
592
AN:
4814
European-Finnish (FIN)
AF:
0.241
AC:
2546
AN:
10570
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.161
AC:
10961
AN:
67998
Other (OTH)
AF:
0.0959
AC:
203
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
814
1628
2441
3255
4069
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.140
Hom.:
1253
Bravo
AF:
0.104
Asia WGS
AF:
0.0380
AC:
137
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.030
DANN
Benign
0.24
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17517598; hg19: chr13-110825264; API